Comprehensive Analysis of Scalded Skin Syndrome: Clinical Exploration, Underlying Pathophysiology and Advanced Therapeutic Approaches
Main Article Content
Abstract
Scalded skin syndrome, a rare but potentially serious dermatologic entity, stands as a clinical and scientific challenge in the contemporary medical field. This article proposes a comprehensive evaluation of this entity, covering clinical aspects, pathophysiological mechanisms and state-of-the-art therapeutic perspectives.
The skin, as the most extensive organ of the human body, is prone to a diversity of pathologies, among which scalded skin syndrome emerges as a condition characterized by significant epidermal exfoliation, commonly evoked by staphylococcal exfoliative toxins. Despite its dramatic clinical presentation, its accurate diagnosis may require meticulous differential evaluation to discern it from other skin conditions with similar manifestations.
From a pathophysiological perspective, cutaneous de-adhesion in scalded skin syndrome originates in the specific unbinding of intracellular adhesion molecules, leading to intraepidermal separation and ultimately intraepidermal blistering. The constantly evolving understanding of the molecular processes involved has led to innovative therapeutic approaches that go beyond mere suppression of the causative infection.
In this comprehensive review, current and emerging therapeutic options are addressed, including intravenous immunoglobulin, immune response modulating agents, and therapies targeting dysfunctional molecular signaling cascades. In addition, the importance of supportive care and prevention of life-threatening complications, such as sepsis, is discussed.
In summary, this article is intended as an essential resource for clinicians, researchers, and healthcare professionals interested in furthering the comprehensive understanding of scalded skin syndrome. The convergence of clinical, basic research, and advanced therapies is crucial to improve early detection, effective management, and prognostic outcomes in this complex dermatologic entity.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Cherry J, Demmler-Harrison GJ, Kaplan SL, Steinbach WJ, Hotez PJ. Feigin and Cherry's Textbook of pediatric infectious diseases. 8th edition. Philadelphia, PA: Saunders/Elsevier; 2018.
II. Long S. Principles and practice of pediatric infectious diseases. 5th edition. Philadelphia, PA: Elsevier; 2018.
III. Hubiche T, Bes M, Roudiere L, Langlaude F, Etienne J, Del Giudice P. Mild staphylococcal scalded skin syndrome: an underdiagnosed clinical disorder. Br J Dermatol. 2012; 166 (1): 213-215.
IV. Hanakawa Y, Stanley JR. Mechanisms of blister formation by staphylococcal toxins. J Biochem. 2004; 136 (6): 747-750.
V. Ladhani S. Understanding the mechanism of action of the exfoliative toxins of Staphylococcus aureus. FEMS Immunol Med Microbiol. 2003; 39 (2): 181-189.
VI. Ladhani S, Joannou CL, Lochrie DP, Evans RW, Poston SM. Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome. Clin Microbiol Rev. 1999; 12 (2): 224-242.
VII. Mishra AK, Yadav P, Mishra A. A systemic review on staphylococcal scalded skin syndrome (SSSS): a rare and critical disease of neonates. Open Microbiol J. 2016; 10: 150159.
VIII. Deghorain M, Van Melderen L. The Staphylococci phages family: an overview. Viruses. 2012; 4 (12): 3316-3335.
IX. Kaplan SL, Deville JG, Yogev R, Morfin MR, Wu E, Adler S et al. Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children. Pediatr Infect Dis J. 2003; 22 (8): 677-686.
X. American Academy of Pediatrics. Staphylococcal infections. In: Kimberlin DW, Brady MT, Jackson MA, Jackson MA, Long SS, eds. Red book: 2015 report of the Committee on Infectious Diseases. 30th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2015. p. 715.
XI. Aydin D, Alsbjorn B. Severe case of staphylococcal scalded skin syndrome in a 5-year-old child - case report. Clin Case Rep. 2016; 4 (4): 416-419.
XII. Haasnoot PJ, De Vries A. Staphylococcal scalded skin syndrome in a 4-year-old child: a case report. J Med Case Rep. 2018; 12 (1): 20.
XIII. Chi CY, Wang SM, Lin HC, Liu CC. A clinical and microbiological comparison of Staphylococcus aureus toxic shock and scalded skin syndromes in children. Clin Infect Dis. 2006; 42 (2): 181-185.